The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
FOX News on MSN15d
FDA bans red food dye due to potential cancer risk
The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary ...
Fact check: Kennedy repeats false and misleading claims in confirmation hearing
In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...
Which Foods Contain Red Dye 3? What To Be Aware Of After FDA Ban, Per Food Safety Expert
Just a few weeks ago on January 15, the Food and Drug Administration (FDA) under the Biden administration revoked authorization of the additive red dye 3, meaning it will be banned from foods and ...
CBS News15d
FDA moves to ban Red 3, citing concern over cancer in some animals
The Food and Drug Administration announced Wednesday it had decided to revoke Red 3's authorization to be added to foods, over concerns about how the food coloring dye has been linked to cancer in ...
phillyvoice.com2d
A new blood test accurately screens for colorectal cancer, researchers say
Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...
Interesting Engineering on MSN5h
Sniffing out cancer: Scientists test nasal drug for deadly pancreatic tumors
A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...
STAT11d
AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
As Trump and RFK Jr. move to upend drug making, Seattle biotech bets on science
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
A grim prognosis, a gamble and one patient’s fight to defy cancer
After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...
Cure Today3d
FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...